✦ LIBER ✦

Cytomegalovirus infection in kidney transplant recipients at our center

✍ Scribed by G Moray; F Köseoglu; H Karakayali; A Demirag; N Bilgin; M Haberal

Book ID: 117238590
Publisher: Elsevier Science
Year: 1999
Tongue: English
Weight: 88 KB
Volume: 31
Category: Article
ISSN: 0041-1345
DOI: 10.1016/s0041-1345(99)00690-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Incidence of Kaposi’s sarcoma in kidney

Incidence of Kaposi’s sarcoma in kidney transplant recipients at our center

✍ H Karakayali; A Demirag; G Moray; E Ersoy; G Arsalan; M Turan; N Bilgin; M Haber 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 61 KB

Cytomegalovirus infection in renal trans

Cytomegalovirus infection in renal transplant recipients

✍ J. Carstens; H.K. Andersen; E. Spencer; M. Madsen 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 188 KB

Monitoring human cytomegalovirus infecti

Monitoring human cytomegalovirus infection in transplant recipients

✍ Fausto Baldanti; Daniele Lilleri; Giuseppe Gerna 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 256 KB

Cytomegalovirus Infection in Kidney Tran

Cytomegalovirus Infection in Kidney Transplant Recipients: Evolution of Approach Through Three Eras

✍ A. Boucher; H. Lord; S. Collette; M. Morin; R. Dandavino 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 61 KB

Cytomegalovirus infection as a complicat

Cytomegalovirus infection as a complication of OKT3 therapy in kidney transplant recipients

✍ P. J. Conlon; M. Carmody; J. Donohoe; S. Spencer; E. Smyth; J. J. Walshe 📂 Article 📅 1992 🏛 Springer-Verlag 🌐 English ⚖ 320 KB

Acyclovir in preventing cytomegalovirus

Acyclovir in preventing cytomegalovirus infection in kidney transplant recipients: A case-controlled study

✍ C. Legendre; D. Ducloux; A. Ferroni; N. Chkoff; C. Geffrier; C. Rouzioux; H. Kre 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 547 KB

High dose oral acyclovir has been reported to be effective in preventing both cytomegalovirus (CMV) infection and disease in renal transplant recipients. We conducted a case-controlled study in which 42 cadaveric kidney transplant recipients were prophylactically treated with high dose oral acyclovi